We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
신규 편입 · 포트폴리오 비중 0.00%
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
US analyst rating / recommendation change.
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
US analyst rating / recommendation change.
US analyst rating / recommendation change.
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
US analyst rating / recommendation change.
실적이 발표되었습니다. 세부 수치와 가이던스는 원문에서 확인하세요.
US analyst rating / recommendation change.
Consensus vs. actual, and revenue trend
Consensus PT $1.55 · 2 analysts
Stored first · Google News · Yahoo Finance (English)
Standard BioTools (LAB) Slides to $0.92 – Support Test in Focus - Inverse ETF Flow - dars.gov.et
Standard BioTools (LAB) Slides to $0.92 – Support Test in Focus - Inverse ETF Flow dars.gov.et
Standard BioTools Inc. (LAB) Surges 5% as Stock Approaches Key Resistance Level - Overnight Profile - dars.gov.et
Standard BioTools Inc. (LAB) Surges 5% as Stock Approaches Key Resistance Level - Overnight Profile dars.gov.et
Standard BioTools (LAB) Surges 5.36% as Shares Test Key Resistance Level - Wave Truncation - dars.gov.et
Standard BioTools (LAB) Surges 5.36% as Shares Test Key Resistance Level - Wave Truncation dars.gov.et
Enterprise value to EBITDA forward of Standard BioTools Inc. – NASDAQ:LAB - TradingView
Enterprise value to EBITDA forward of Standard BioTools Inc. – NASDAQ:LAB TradingView
Price to book forward of Standard BioTools Inc. – NASDAQ:LAB - TradingView
Price to book forward of Standard BioTools Inc. – NASDAQ:LAB TradingView
Price to sales forward of Standard BioTools Inc. – BOATS:LAB - TradingView
Price to sales forward of Standard BioTools Inc. – BOATS:LAB TradingView
| Quarter | Date | Time | EPS est. | EPS actual | Surprise | Rev. est. | Rev. actual | Status |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 05. 05. | After market close (AMC) | — | — | — | $20.8M | — | Scheduled |
| FY2026 Q1 | 2025. 03. 31. | Time TBD | — | $-0.07 | — | — | $20.22M | Reported |
| FY2025 Q3 | 2024. 09. 30. | Time TBD | — | $-0.44 | — | — | $66.23M | Reported |
| FY2025 Q2 | 2024. 06. 30. | Time TBD | — | $-0.37 | — | — | $44.15M | Reported |
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2025. 11. 06. | TD Cowen | — | Maintain | Hold → Hold | — | TD Cowen: Hold |
| 2025. 02. 27. | Keybanc | — | Downgrade | Overweight → Sector Weight | — | Keybanc: Overweight → Sector Weight |
| 2024. 11. 01. | TD Cowen | — | Maintain | Buy → Buy | — | TD Cowen: Buy |
| 2024. 08. 02. | TD Cowen | — | Maintain | Buy → Buy | — | TD Cowen: Buy |
| 2024. 04. 16. | TD Cowen | — | Initiate coverage | — → Buy | — | TD Cowen: Buy |
| 2024. 04. 04. | Jefferies | — | Initiate coverage | — → Buy | — | Jefferies: Buy |
As of FY2026Q1 · Source: SEC/DART + price data
| # | Institution | Mandate | Shares | Value | Weight | Change | Position |
|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 143,307 | $183.43K | 0.00% | — | New position |
| 2 | Point72 Asset Management, L.P. | Point72 Asset Management, L.P. | 44,721 | $41.11K | 0.00% | — | New position |